Publizoom

Award notice Supplies

Spécialité pharmaceutique à base de Sugammadex

Notice published in French. The AI analysis summarises it for you in your language.

Public buyer
Association iris-Achats
Saint-Gilles
Place of performance
1090 Bruxelles, Brussels-Capital
Amount awarded
€295,240 excl. VAT
Planned end of contract
20 December 2027
likely re-tender around June 2027
Bids received
4
Procedure
Open procedure
Any company may submit a bid.
Publication
9 January 2024
Notice language
French

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Spécialité pharmaceutique à base de Sugammadex

Awarded to

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below
€269,390
Median
€449,863
A quarter above
€962,736

Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

ContractWinnerAmount
Héparines à bas poids moléculaire
Association iris-Achats · 14 February 2025
Viatris
Leo Pharma
€1,060,601
Spécialités pharmaceutiques à base de Ranibizumab
Association iris-Achats · 9 January 2025
Teva Pharma Belgium €1,496,000
Spécialités pharmaceutiques à base d'infliximab IV
Association iris-Achats · 3 July 2024
Biogen NV/SA €2,115,713
Raamovereenkomst: aankoop CPT intra-vitreale injectie
vzw Jessa Ziekenhuis · 22 October 2026
DE CEUNYNCK MEDICAL €604,000
Leveren van orale antibiotica
UZ Leuven · 16 October 2026
Pfizer
Viatris
Arega Pharma
EUMEDICA
€1,032,354

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 13176-2024.